Document Detail


Pulmonary disease as a complication of chlorozotocin chemotherapy.
MedLine Citation:
PMID:  6453644     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Two of 200 patients treated with chlorozotocin have evidenced interstitial pulmonary disease. The cumulative doses of chlorozotocin were 480 and 670 mg/m2 when symptoms developed. Pulmonary function tests in both patients showed impaired diffusion, and an alveolar-arterial gradient which worsened with exercise. Open-lung biopsy in one patient showed typical interstitial inflammation and early fibrosis, and excluded lymphangitic spread of tumor. Discontinuation of chlorozotocin resulted in either improvement or stabilization of the pulmonary disease.
Authors:
J D Ahlgren; F P Smith; D M Kerwin; B I Sikic; J H Weiner; P S Schein
Related Documents :
19282344 - Pulmonary arterial hypertension in limited cutaneous systemic sclerosis: a distinctive ...
15072224 - Increased level of soluble e-selectin in the serum from patients with idiopathic pulmon...
589074 - Effects of sputum on pulmonary function.
25178334 - The macroscopic examination of the placental vasculature with a corrosive agent.
703374 - Arch versus femoral artery perfusion during cardiopulmonary bypass.
16350684 - Covered stents deployed for coarctation of aorta with aneurysm.
Publication Detail:
Type:  Case Reports; Journal Article    
Journal Detail:
Title:  Cancer treatment reports     Volume:  65     ISSN:  0361-5960     ISO Abbreviation:  Cancer Treat Rep     Publication Date:    1981 Mar-Apr
Date Detail:
Created Date:  1981-08-20     Completed Date:  1981-08-20     Revised Date:  2004-11-17    
Medline Journal Info:
Nlm Unique ID:  7607107     Medline TA:  Cancer Treat Rep     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  223-9     Citation Subset:  IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Antineoplastic Agents / adverse effects*
Biopsy
Female
Humans
Lung Diseases / chemically induced*,  pathology
Lung Volume Measurements
Neoplasms / complications,  drug therapy*
Pulmonary Fibrosis / chemically induced
Streptozocin / adverse effects,  analogs & derivatives*
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 18883-66-4/Streptozocin; 54749-90-5/chlorozotocin

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Autopsy findings in 111 cases of esophageal cancer.
Next Document:  Treatment of advanced soft tissue sarcoma with chlorozotocin: a phase II trial of the EORTC soft tis...